Lana Ilic Prelogovic, Gorana Perina Lakoš and Marina Krstanovic examine the availability of information that generics companies need to develop their products. The development of generic pharmaceuticals requires a comprehensive approach in terms of the analysis of data relating to the relevant reference product or products...
Please login to read the full article.
scr
RAJ Pharma
A Review of Regulatory Authority Databases in Central and Eastern Europe for the Purposes of Generic Pharmaceutical Development
27 October 2009
Lana Ilic Prelogovic, Gorana Perina Lakoš and Marina Krstanovic
Not a subscriber ? Request a FREE Trial
Subscribe to RAJ Pharma
RELATED CONTENT
NEWS
RAJ Pharma News
- Advocate General?s Opinion from the ECJ Finds Public Bodies? Prescribing Incentive Schemes to be Unlawful
- Europe's regulator attacked for "secrecy" over drug data
- Proposed changes to ABPI code of practice could hurt smaller firms, warns EMIG - update
- Few firms benefit from rewards under EU Paediatric Regulation
Other Informa News
ANALYSIS
RAJ Pharma Analysis
Other Informa Analysis
EDITORIALS
RAJ Pharma Editorials
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
RAJ Pharma Comment
Other Informa Comments
EVENTS
September 15th, 2010
London, UK
September 16th, 2010
Basel, Switzerland
September 20th, 2010
London, UK